- Home
- LESL vs NTRB Comparison
LESL vs NTRB Comparison
Compare LESL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- NTRB
- Stock Information
- Founded
- LESL 1963
- NTRB 2016
- Country
- LESL United States
- NTRB United States
- Employees
- LESL N/A
- NTRB N/A
- Industry
- LESL Diversified Commercial Services
- NTRB Industrial Specialties
- Sector
- LESL Miscellaneous
- NTRB Health Care
- Exchange
- LESL Nasdaq
- NTRB Nasdaq
- Market Cap
- LESL 66.9M
- NTRB 71.7M
- IPO Year
- LESL 2020
- NTRB N/A
- Fundamental
- Price
- LESL $2.95
- NTRB $5.60
- Analyst Decision
- LESL Hold
- NTRB Buy
- Analyst Count
- LESL 9
- NTRB 1
- Target Price
- LESL $33.25
- NTRB $13.00
- AVG Volume (30 Days)
- LESL 132.8K
- NTRB 44.1K
- Earning Date
- LESL 11-25-2025
- NTRB 12-03-2025
- Dividend Yield
- LESL N/A
- NTRB N/A
- EPS Growth
- LESL N/A
- NTRB N/A
- EPS
- LESL N/A
- NTRB N/A
- Revenue
- LESL $1,250,568,000.00
- NTRB $2,578,059.00
- Revenue This Year
- LESL N/A
- NTRB $560.75
- Revenue Next Year
- LESL N/A
- NTRB $588.39
- P/E Ratio
- LESL N/A
- NTRB N/A
- Revenue Growth
- LESL N/A
- NTRB 42.92
- 52 Week Low
- LESL $2.80
- NTRB $2.98
- 52 Week High
- LESL $72.60
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- LESL 43.78
- NTRB 33.25
- Support Level
- LESL $3.04
- NTRB $5.55
- Resistance Level
- LESL $3.35
- NTRB $6.39
- Average True Range (ATR)
- LESL 0.29
- NTRB 0.47
- MACD
- LESL -0.13
- NTRB -0.09
- Stochastic Oscillator
- LESL 15.29
- NTRB 0.00
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.